Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4.54%59.22M | -19.72%215.96M | -33.59%61.23M | -26.25%46.59M | 2.12%51.66M | -10.34%56.65M | 37.49%269.02M | 114.21%92.2M | 21.06%63.17M | 2.02%50.59M |
| Net interest income | -1.90%15.61M | 23.75%63.35M | 10.40%15.67M | 29.87%15.49M | 27.76%16.27M | 29.04%15.92M | -4.17%51.2M | 9.58%14.2M | -12.53%11.93M | -4.86%12.74M |
| -Total interest income | -4.41%48.1M | 7.35%195.17M | 2.19%48.39M | 6.50%48.04M | 7.39%48.43M | 13.72%50.32M | 17.15%181.8M | 15.34%47.36M | 9.56%45.11M | 19.37%45.1M |
| -Total interest expense | -5.58%32.48M | 0.93%131.82M | -1.32%32.72M | -1.90%32.55M | -0.63%32.15M | 7.80%34.4M | 28.33%130.61M | 18.00%33.16M | 20.50%33.18M | 32.67%32.36M |
| Non interest income | 7.06%43.61M | -29.94%152.61M | -41.60%45.56M | -39.31%31.1M | -6.50%35.39M | -19.89%40.73M | 53.14%217.82M | 159.26%78.01M | 32.95%51.24M | 4.56%37.85M |
| -Fees and commissions | -24.02%27.57M | -14.03%129.08M | -40.68%31.84M | -10.86%29.85M | -0.20%31.11M | 14.02%36.28M | 29.12%150.15M | 96.16%53.67M | 12.17%33.49M | 5.96%31.17M |
| -Including:Fees and commission income | -24.02%27.57M | -14.03%129.08M | -40.68%31.84M | -10.86%29.85M | -0.20%31.11M | 14.02%36.28M | 29.12%150.15M | 96.16%53.67M | 12.17%33.49M | 5.96%31.17M |
| -Dividend income | -35.56%2.16M | -43.39%8.03M | -52.49%1.32M | -61.58%1.86M | -50.87%1.5M | -4.71%3.36M | 15.40%14.18M | -14.48%2.77M | 56.46%4.85M | 19.41%3.05M |
| -Gain loss on sale of securities | 50.82%10.16M | -62.73%18.5M | -31.16%15.37M | -128.94%-3.3M | -105.46%-309K | -34.18%6.74M | 4,979.32%49.63M | 1,249.69%22.33M | 201.80%11.4M | 24.43%5.66M |
| -Net reversal of impairment loss of financial instruments | 254.29%54K | -190.65%-97K | -255.00%-31K | -500.00%-16K | -123.44%-15K | -284.21%-35K | 1,088.89%107K | -28.57%20K | 150.00%4K | 1,014.29%64K |
| -Total other operating income | -54.74%3.03M | 424.09%8.95M | 1,946.69%11.44M | 133.79%2.18M | -3,991.32%-11.21M | 126.84%6.7M | 85.51%-2.76M | 106.39%559K | 20.41%-6.45M | -93.96%288K |
| Credit losses provision | 103.11%5K | 82.93%-28K | 37.50%-40K | 31.03%-60K | 86.40%233K | -16.67%-161K | 5.75%-164K | 13.51%-64K | -162.14%-87K | 201.63%125K |
| Operating expense | -1.19%34.71M | -6.45%138.47M | -11.27%39.63M | -13.08%31.65M | 3.11%32.05M | -2.01%35.13M | 9.57%148.02M | 27.21%44.66M | 1.83%36.42M | -8.44%31.09M |
| Staff costs | -2.74%22M | -8.27%89.5M | -14.80%26.51M | -19.17%19.46M | 13.52%20.91M | -5.59%22.62M | 8.24%97.57M | 31.45%31.12M | -3.41%24.07M | -16.97%18.42M |
| Selling and administrative expenses | 9.79%7.06M | 1.30%25.48M | -1.46%7.11M | 1.55%6.34M | -11.37%5.6M | 19.62%6.43M | 24.86%25.15M | 39.67%7.21M | 35.37%6.25M | 14.09%6.32M |
| -Selling and marketing expense | -17.78%564K | 7.89%2.53M | 10.77%648K | -19.06%726K | 14.08%470K | 52.11%686K | 4.27%2.35M | 55.17%585K | 10.33%897K | -35.32%412K |
| -General and administrative expense | 13.08%6.49M | 0.62%22.95M | -2.54%6.46M | 5.01%5.62M | -13.15%5.13M | 16.64%5.74M | 27.44%22.81M | 38.45%6.63M | 40.73%5.35M | 20.51%5.91M |
| Depreciation and amortization | -18.01%1.7M | -25.65%7.25M | -22.57%1.68M | -27.22%1.73M | -31.88%1.76M | -20.63%2.08M | -10.13%9.75M | -20.74%2.17M | -14.09%2.38M | -4.29%2.59M |
| -Depreciation | -15.64%1.21M | -32.38%4.94M | -23.85%1.18M | -34.19%1.16M | -40.96%1.16M | -28.97%1.44M | -14.44%7.3M | -26.92%1.55M | -18.27%1.76M | -7.81%1.97M |
| -Amortization | -23.35%489K | -5.56%2.31M | -19.35%500K | -7.43%573K | -2.76%598K | 7.95%638K | 5.80%2.45M | 0.49%620K | 0.49%619K | 9.04%615K |
| Rent and land expenses | 13.04%26K | 87.29%221K | 61.18%137K | 312.50%33K | 133.33%28K | 76.92%23K | -15.11%118K | 142.86%85K | -88.06%8K | -29.41%12K |
| Other operating expenses | -1.46%3.93M | 3.82%16.03M | 2.77%4.19M | 10.06%4.09M | 0.16%3.76M | 2.47%3.99M | 11.63%15.44M | 16.50%4.08M | 9.45%3.72M | 6.78%3.75M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 1,550.00%66K | 509.30%262K | -533.33%-38K | 128.46%281K | -77.94%15K | 102.82%4K | -84.01%43K | -101.01%-6K | 0.82%123K | 115.11%68K |
| Less:Other special charges | ---29K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | -825.00%-37K | -509.30%-262K | 533.33%38K | -128.46%-281K | 77.94%-15K | -102.82%-4K | -26.47%-43K | 101.51%6K | -44.71%-123K | -115.11%-68K |
| Other non-operating income (expenses) | -44.83%64K | 3.36%676K | 5.35%335K | -53.60%58K | ---- | 24.73%116K | 55.34%654K | 14.80%318K | 204.88%125K | ---- |
| Income before tax | 13.02%24.63M | -35.62%78.46M | -54.21%21.94M | -43.38%15.34M | -0.28%19.39M | -20.50%21.79M | 98.38%121.86M | 439.72%47.92M | 64.78%27.09M | 27.02%19.45M |
| Income tax | 7.74%5.72M | -16.40%20.02M | -61.46%4.3M | -4.09%4.43M | 71.10%5.99M | 13.54%5.31M | 107.32%23.95M | 1,260.98%11.16M | 41.51%4.62M | 29.41%3.5M |
| Net income | 14.72%18.91M | -40.32%58.44M | -52.01%17.64M | -51.46%10.91M | -15.94%13.41M | -27.50%16.48M | 96.31%97.91M | 356.14%36.76M | 70.54%22.47M | 26.51%15.95M |
| Net income continuous operations | 14.72%18.91M | -40.32%58.44M | -52.01%17.64M | -51.46%10.91M | -15.94%13.41M | -27.50%16.48M | 96.31%97.91M | 356.14%36.76M | 70.54%22.47M | 26.51%15.95M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 14.72%18.91M | -40.32%58.44M | -52.01%17.64M | -51.46%10.91M | -15.94%13.41M | -27.50%16.48M | 96.31%97.91M | 356.14%36.76M | 70.54%22.47M | 26.51%15.95M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 14.72%18.91M | -40.32%58.44M | -52.01%17.64M | -51.46%10.91M | -15.94%13.41M | -27.50%16.48M | 96.31%97.91M | 356.14%36.76M | 70.54%22.47M | 26.51%15.95M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 14.29%0.08 | -40.24%0.248 | -51.92%0.075 | -51.58%0.046 | -16.18%0.057 | -27.08%0.07 | 95.75%0.415 | 345.71%0.156 | 69.64%0.095 | 28.30%0.068 |
| Diluted earnings per share | 14.29%0.08 | -40.24%0.248 | -51.92%0.075 | -51.58%0.046 | -16.18%0.057 | -27.08%0.07 | 95.75%0.415 | 345.71%0.156 | 69.64%0.095 | 28.30%0.068 |
| Dividend per share | 0 | 29.41%0.22 | 0 | 0 | 29.41%0.22 | 0 | -10.53%0.17 | 0 | 0 | -10.53%0.17 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.